A Case of Suspected Lisdexamfetamine (Vyvanse) Drug-Induced Liver Injury

Authors

Louis Kishfy, MD, Thomas Jefferson UniversityFollow
Justin Bilello, MD, Thomas Jefferson UniversityFollow
Monjur Ahmed, MD, Thomas Jefferson UniversityFollow
Elizaveta Flerova, MD, Thomas Jefferson UniversityFollow

Abstract

Amphetamines are a well-established cause of liver injury though the typical presentation is that of illicit drug abuse rather than liver injury occurring in a prescribed setting.¹ Lisdexamfetamine (Vyvanse) is one of the most commonly prescribed stimulant medications used for the treatment of Attention Deficit Hyperactive Disorder (ADHD). The authors were only able to find a single case of lisdexamfetamine-related drug-induced liver injury (DILI) occurring in the pediatric population in their review of the literature. Here we present a case of suspected lisdexamfetamine DILI in an adult patient.

Recommended Citation

Kishfy, MD, Louis; Bilello, MD, Justin; Ahmed, MD, Monjur; and Flerova, MD, Elizaveta (2023) "A Case of Suspected Lisdexamfetamine (Vyvanse) Drug-Induced Liver Injury," The Medicine Forum: Vol. 24, Article 12.
DOI: https://doi.org/10.29046/TMF.024.1.011
Available at: https://jdc.jefferson.edu/tmf/vol24/iss1/12